Company intelligence / Profile preview

CIB

Madrid, Madrid, Spaincib.csic.es ↗
Ownership
Private
Employees
~500
Development stage
Other
01

Overview

The Centro de Investigaciones Biológicas Margarita Salas (CIB) is a leading research center within the Spanish National Research Council (CSIC) that operates at the intersection of biology, chemistry, and medicine. While primarily a research institution, it functions as a biotech incubator and technology provider, spinning off numerous companies and licensing advanced therapeutic candidates. The center focuses on structural biology, cellular and molecular medicine, and environmental biotechnology, with a strong emphasis on neurodegenerative diseases and oncology. CIB provides a robust pipeline of early-stage drug candidates and diagnostic tools through its specialized technology platforms. Its business model involves extensive collaboration with pharmaceutical partners to translate basic research into clinical applications.

Therapeutic areas
Infectious DiseasesRare DiseasesNeurologyImmunologyOncology
Modalities
Small moleculeMonoclonal antibodyVaccineBiologicPeptides
Industry
Academic Hospital/University/Research
02

Partnerships

GlaxoSmithKlineAlmirallPharmaMarZeltia

Beyond the preview

Go deeper on CIB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CIB.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call